Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced that it plans to offer 2,500,000 shares of its common stock in an underwritten ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE